Akari Therapeutics plc ADR (0.01 USD) (AKTX) is a publicly traded Healthcare sector company. As of May 21, 2026, AKTX trades at $3.51 with a market cap of $4.01M and a P/E ratio of 0.00. AKTX moved +0.53% today. Year to date, AKTX is -70.85%; over the trailing twelve months it is -93.40%. Its 52-week range spans $3.02 to $148.00. Analyst consensus is buy with an average price target of $27.00. Rallies surfaces AKTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Akari Therapeutics plc ADR (0.01 USD) (AKTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AKTX moved +0.53% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.51 |
| Market Cap | $4.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $148.00 |
| 52-Week Low | $3.02 |
| Volume | 3.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-17.30M |
| Gross Margin | 0.00% |
2 analysts cover AKTX: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.00.